Primary malignant melanoma of uterine cervix treated with pembrolizumab as adjuvant immunotherapy

This is the case report of primary malignant melanoma (MM) of uterine cervix treated by immune checkpoint inhibitor: the Pembrolizumab. Despite the merge of the novel drugs that has been strikingly improving prognosis of MM, we still struggle treatment of MM of uterine cervix that has aggressive cha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Cancer Conf J
Main Authors: Suzuki, Reiko, Endo, Hiraku, Sasaki, Takamichi, Nakamura, Takayoshi, Yamanaka, Hiroyuki, Hosonuma, Shinji, Kuji, Shiho, Deura, Imari, Ohara, Tatsuru, Kondo, Haruhiro, Chosokabe, Motohiro, Koike, Junki, Kadono, Hiroshi, Hasegawa, Junichi, Suzuki, Nao
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2021
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8206436/
https://ncbi.nlm.nih.gov/pubmed/34221842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-021-00477-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados